No Data
No Data
Why Chimerix, Inc. (CMRX) Soared Last Week
The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Update: Truist Raises PT on Jazz Pharmaceuticals to $230 From $220 on Heels of Announced Purchase of Chimerix, Keeps Buy Rating
Chimerix Downgraded to Neutral From Buy at H.C. Wainwright
This MongoDB Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Unlock the Full List
Short Term Trading OP : the additional payout will be in shares?
72057252 : are you currently thinking of rolling?
101674396 72057252 : chance to rise ? hold or sell